Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer

Ann Oncol. 2005 Nov;16(11):1848-9. doi: 10.1093/annonc/mdi356. Epub 2005 Jul 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / secondary
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics*
  • Gefitinib
  • Humans
  • Mutation / drug effects*
  • Mutation / genetics*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • ErbB Receptors
  • Gefitinib